Home - Products - Cell Cycle/DNA Damage - GPR - 1-methoxycyclopropanecarboxylic acid

1-methoxycyclopropanecarboxylic acid

CAS No. 100683-08-7

1-methoxycyclopropanecarboxylic acid( —— )

Catalog No. M28687 CAS No. 100683-08-7

1-methoxycyclopropanecarboxylic acid is an agonist of free fatty acid receptor 3 (FFAR3, human).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 29 Get Quote
5MG 45 Get Quote
10MG 68 Get Quote
25MG 115 Get Quote
50MG 173 Get Quote
100MG 258 Get Quote
200MG 388 Get Quote
500MG 642 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    1-methoxycyclopropanecarboxylic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    1-methoxycyclopropanecarboxylic acid is an agonist of free fatty acid receptor 3 (FFAR3, human).
  • Description
    1-methoxycyclopropanecarboxylic acid is an agonist of free fatty acid receptor 3 (FFAR3, human).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    GPR
  • Recptor
    Antifungal
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    100683-08-7
  • Formula Weight
    116.116
  • Molecular Formula
    C5H8O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COC1(CC1)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wang, S.Y., Sun, T., and Faust, M.Translocation of paclobutrazol, a gibberellin biosynthesis inhibitor, in apple seedlingsPlant Physiology82(1)11-14(1986)
molnova catalog
related products
  • cangrelor tetrasodiu...

    Cangrelor tetrasodium is a reversible and selective antagonist of platelet P2Y12, with prompt and potent antiplatelet effects.cangrelor, a non-sepesific GPR17 antagonist, alleviates pulmonary fibrosis partly by inhibiting macrophage inflammation in mice.

  • PSB-CB5

    PSB-CB5 (GPR18-IN-32)2 is a GRP18 antagonist with anti-inflammatory activity and can be used to study obesity and metabolic disorders.

  • Bimatoprost acid

    Bimatoprost acid is a metabolically stable analog of PGF2α and has a potential antagonistic activity for the FP receptor.